Xiangli Jiang
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 3
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
-
- Lung Cancer Research Studies 7
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 4
-
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 2
- Journals
- Cancer Biology and Medicine (2 papers)Tumor Biology (2 papers)Patient Preference and Adherence (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xiangli Jiang
21 papers receiving 508 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 222
- Oncology 171
- Pulmonary and Respiratory Medicine 171
- Molecular Biology 307
- Immunology 45
Countries citing papers authored by Xiangli Jiang
This map shows the geographic impact of Xiangli Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangli Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangli Jiang more than expected).
Fields of papers citing papers by Xiangli Jiang
This network shows the impact of papers produced by Xiangli Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangli Jiang. The network helps show where Xiangli Jiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiangli Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 13 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 6 | |
| 6 | 2021 | 33 | |
| 7 | 2021 | 45 | |
| 8 | 2020 | 15 | |
| 9 | 2019 | 19 | |
| 10 | 2019 | 18 | |
| 11 | 2018 | 58 | |
| 12 | 2018 | 26 | |
| 13 | 2018 | 103 | |
| 14 | 2018 | 23 | |
| 15 | 2017 | 10 | |
| 16 | 2017 | 3 | |
| 17 | 2017 | 1 | |
| 18 | 2015 | 13 | |
| 19 | 2014 | 7 | |
| 20 | 2013 | 54 |
About Xiangli Jiang
Xiangli Jiang is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 512 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (222 citations), Oncology (171 citations) and Pulmonary and Respiratory Medicine (171 citations). Xiangli Jiang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiubao Ren, Qian Sun, Hui Li, Kai Li, Zhongli Zhan, Dingzhi Huang, Chun Huang, Jingya Wang, Xia Wang and Zhiqiang Wu. Their work appears in journals such as Cancer Biology and Medicine, Tumor Biology, Patient Preference and Adherence, Molecular Oncology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.